|
|
Article: Deal With GSK Gives Celgene Multiple Myeloma Drug To Sell.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Associate Managing Editor
Celgene Corp. formed a promotion and distribution deal with GlaxoSmithKline plc for the pharmaceutical company's multiple myeloma product, Alkeran, now giving Celgene an official reason to be in contact with physicians in that disease arena.
The deal calls for Celgene, of Warren, N.J., to buy Alkeran tablets and Alkeran for injection from London-based GSK and then distribute the product under Celgene's label. Celgene will have no manufacturing or quality assurance responsibility. Financial details of the arrangement were not disclosed, but Brian Gill, Celgene's director of investor relations and public relations, said the deal ...